JONATHAN E. WILSON,Petr Vachal,Ravi Kurukulasuriya
申请号：
US15028306
公开号：
US20160355474A1
申请日:
2014.10.06
申请国别(地区):
US
年份:
2016
代理人:
摘要：
3,3′-Disubstituted indoline compounds, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.
